Acadia Pharmaceuticals Inc 10-K for FY2024
Acadia Pharmaceuticals Inc (ACAD)
10-K
2025-02-27
For: 2024-12-31
View Original
Added on
April 04, 2026
About this 10-K
Acadia Pharmaceuticals Inc filed this 10-K on February 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $957.8M
- up 31.8% from $726.44M a year earlier
- Net income
- $226.45M
- compared with a net loss of $61.29M a year earlier
- Diluted EPS
- $1.36
- compared with -$0.37 a year earlier